Cite
HARVARD Citation
Diver, S. et al. (2021). Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 9 (11), pp. 1299-1312. [Online].